関連する実験動画
Updated: Feb 15, 2026

09:25
Bioluminescent Orthotopic Model of Pancreatic Cancer Progression
Published on: June 28, 2013
27.6K
CEP55はフェロプトーシスを抑制することによって,臓がんの進行を促します
Shuhan Zhang1, Jiaqi Chai2, Wenjuan Zhang3
1Department of Hepatobiliary Surgery, Air Force Medical Center, PLA, Air Force Medical University, Beijing, China.
BioFactors (Oxford, England)
|February 14, 2026
まとめ
セントロソマルタンパク質55 (CEP55) は,細胞死経路であるフェロプトーシスを抑制することによって,臓がんを誘発する. CEP55を阻害することは,この致命的な病気に対する新しい治療戦略を提供することができる.
科学分野:
- 腫瘍学 腫瘍学
- 細胞生物学 細胞生物学
- バイオケミストリー バイオケミストリー
背景:
- 臓がん (PC) は致命的な悪性腫瘍であり,有意な治療抵抗性を持っています.
- 鉄に依存する細胞死であるフェロプトーシス (ferroptosis) はPC.で関与しているが,完全に理解されていない.
- PCにおけるセントロソーマルタンパク質55 (CEP55) の腫瘍性作用はほとんど不明である.
研究 の 目的:
- 臓がんの進行におけるCEP55の役割を調査する.
- CEP55とPCにおけるフェロプトーシスの関係を調査する.
- CEP55を潜在的予後バイオマーカーおよび治療標的として評価する.
主な方法:
- 免疫ヒストケミカル検証による統合TCGAデータ分析.
- PC細胞でCEP55ノックダウンと過剰発現の研究を行った.
- 評価されたフェロプトーシスマーカー (脂質過酸化,鉄,グルタチオン) と主要なフェロプトーシス調節物質.
- エラスティン (フェロプトーシス誘発剤) をCEP55調節と併用した.
- 腫瘍の成長とフェロプトーシスマーカーを評価するために,Xenograftの研究を in vivoで行いました.
主要な成果:
- CEP55はPCで著しく過剰に発現し,病気が進行し,予後が悪いと相関しています.
- CEP55のノックダウンにより,PC細胞の増殖,移動,およびクローノジェニシティが抑制されました.
- CEP55はGPX4やSLC7A11のような抑制剤をダウンレギュレーションすることによって,フェロプトーシス誘発フェロプトーシスを静止させ,フェロプトーシスストレスに対する感受性を高めます.
- エラスティンはCEP55欠乏細胞におけるフェロプトーシスを強化し,CEP55の腫瘍促進効果を相殺した.
- In vivoでは,CEP55の静止は腫瘍の成長を減少させ,フェロプトーシスマーカーを調節した.
結論:
- CEP55は,フェロプトーシスを抑制することによって,臓がんの進行の新たな原動力として作用します.
- CEP55は,PCの潜在的な予後バイオマーカーです.
- CEP55を標的とし,おそらくフェロプトーシス誘発剤と組み合わせれば,PC耐性を克服するための有望な治療戦略となります.
関連する概念動画
mTOR Signaling and Cancer Progression
4.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.9K
Energy to Drive Translocation
2.9K
Mitochondrial protein import is powered by two distinct energy sources: ATP hydrolysis and electrochemical potential across the inner membrane. Newly synthesized precursors are bound by cytosolic chaperones of the Hsp70 family, which guide them to the import receptors on the mitochondrial surface. Utilizing the energy of ATP hydrolysis, Hsp70 chaperones transfer these precursors to the TOM receptors on the mitochondrial outer membrane.
Generally, polypeptides are unfolded by two distinct...
Generally, polypeptides are unfolded by two distinct...
2.9K
M-Cdk Drives Transition Into Mitosis
6.6K
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
6.6K
Tumor Progression
7.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.5K
Drive-Reduction Theory: Push Theory of Motivation
1.3K
Clark Hull's drive-reduction theory, introduced in the 1940s and 1950s and often termed the "push theory" of motivation, provides a framework for understanding how biological and learned drives influence behavior. Hull suggested that motivation originates from the need to alleviate physiological tension caused by unmet biological necessities. The theory proposes that when a basic need, such as hunger or sleep, goes unfulfilled, it creates an internal imbalance. This imbalance, or...
1.3K
Acid Suppressive Drugs for Peptic Ulcer Disease: Antacids
715
In the complex environment of the gastric lumen, excessive acid secretion can lead to the formation or worsening of ulcers within the delicate mucosal layer. Antacids, such as sodium bicarbonate and calcium carbonate, provide relief by neutralizing this acid, transforming it into harmless salt and water. This neutralization process raises the gastric pH from a highly acidic level of 1 to a more basic 3-4, reducing the acidity within the stomach.
However, this neutralization reaction between...
However, this neutralization reaction between...
715

